Randomized, Double-blind, Placebo-controlled Sequential Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SCYX-7158 After Single Oral Ascending Doses in Healthy Male Volunteers
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2015
Price : $35 *
At a glance
- Drugs Acoziborole (Primary)
- Indications Trypanosomiasis
- Focus Adverse reactions
- 08 Sep 2015 Results published in a Drugs for Neglected Diseases Initiative Foundation media release.
- 24 Jun 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
- 23 May 2014 According to a Drugs for Neglected Diseases initiative media release, this trial is ending tests in healthy volunteers.